Propeller Health, GSK expand their collaboration to improve management of asthma and COPD
The two companies will undertake commercial activities using the Propeller clip-on sensor and software platform for use with GSK's ELLIPTA Inhaler.
Propeller Health updates its app to add access to pharmacy services from CVS, Walmart,...
With the expansion of the My Pharmacy feature, patients can use Propeller to refill prescriptions with 5 of the 7 largest pharmaceutical providers in the U.S.
Propeller Health to create custom sensor for GSK’s Ellipta inhaler
GSK will use the sensor in the studies to automatically collect and record data on the inhaler's usage, and wirelessly transmit the data collected.
Propeller Health launches inhaler technique coaching via Google Helpouts
People with any chronic respiratory disease and their family caregivers can get personalized inhaler technique coaching and answers to their questions.
Propeller Health unveils its very first API
Called Air by Propeller, it provides local asthma conditions to anyone in the US who would like to share this insight with their audiences.
Propeller Health, Orion to bring new digital medicines to people with asthma and COPD
Under the deal, Orion's existing line of Easyhaler products will connect to Propeller's digital medicine platform via a small, custom-built sensor.
FDA clears Propeller’s platform in association with Boehringer Ingelheim’s an GSK’s inhalers
FDA-approved marketing claims of improved adherence and reduction in exacerbations address key unmet needs in respiratory health.
Propeller Health, Boehringer Ingelheim team-up to improve for asthma and COPD patients
Patients will have the opportunity to enroll in a new program to determine how Propeller's hi-tech tool can impact adherence rates and patient engagement.
Propeller, Novartis to develop add-on sensor for COPD patients
The new custom sensors will allow for passively recording compliance data, better informing patients and their physicians of adherence and other factors.
Propeller, Aptar partner to develop connected metered dose inhaler
The sensor-laden device with a novel electronic dose counter is currently available for licensing and is expected to enter clinical studies later this year.